April 5, 2021

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.  20549

Attention: Jeffrey Kauten

 

 

Re:CM Life Sciences III Inc.
  Registration Statement on Form S-1
  Filed February 25, 2021 as amended
  File No. 333-253475



Dear Mr. Kauten:

 

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for itself and the several underwriters, hereby join in the request of CM Life Sciences III Inc. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on April 6, 2021, or as soon thereafter as practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advise that approximately 150 copies of the Preliminary Prospectus dated March 25, 2021 are expected to be distributed to prospective underwriters and dealers, institutional investors, retail investors and others.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

* * *

 

[Signature page follows]

 

 

 

 

  Very truly yours,
   
  JEFFERIES LLC
  COWEN AND COMPANY, LLC
  as Representatives of the Several Underwriters
   
  JEFFERIES LLC
   
   
  By:  /s/ Scott M. Skidmore
    Name: Scott M. Skidmore
Title: Managing Director

 

  COWEN AND COMPANY, LLC
   
  By:  /s/ E. James Streator, III
    Name: E. James Streator, III
Title: Managing Director